Sentry Page Protection
MMI Scenario 4
You are working within a busy GP practice and have been tasked by the on-call GP to undertake a discharge medication review from a patient under the care of Rheumatology who has been previously receiving Methotrexate 15mg weekly at your local hospital. Last bloods (FBC,CRP, ESR, U+Es, LFTs) were normal four weeks ago and the specialist team wishes for the care to be discharged back into primary care. What further issues do you wish to explore before inviting the patient in for a discharge review and potentially issuing this medicine? What would support you and the practice in the safe transfer of care for this patient?